Membrane Anchors Stabilize Proteins in Prion Diseases
Researchers have gained valuable insight into the development of prion diseases of the brain.
Complete the form below to unlock access to ALL audio articles.
Summary
Researchers at Ruhr University Bochum discovered that a lipid anchor on nerve cell membranes stabilizes prion protein folding, preventing harmful aggregation linked to prion diseases. Their in vitro and cell culture models show how these anchors inhibit clumping, offering potential pathways for treatments targeting the cellular mechanisms of neurodegenerative disorders.
Key Takeaways
Protein aggregation is typical of various neurodegenerative diseases such as Alzheimer’s, Parkinson’s and prion diseases such as Creutzfeld-Jakob disease. A research team headed by Professor Jörg Tatzelt from the Department of Biochemistry of Neurodegenerative Diseases at Ruhr University Bochum, Germany, has now used new in vitro and cell culture models to show that a lipid anchor on the outer membrane of nerve cells inhibits the aggregation of the prion protein. “Understanding the mechanisms that cause the originally folded proteins to transform into pathogenic forms is of crucial importance for the development of therapeutic strategies,” says Jörg Tatzelt. The team published their findings in the journal Proceedings of the National Academy of Sciences (PNAS) on December, 31, 2024.
Hereditary and infectious forms of the disease
Prion diseases are fatal degenerative diseases of the brain. They are associated with the transformation of the cellular prion protein (PrPC) from its healthy fold into pathological aggregates, i.e. scrapie prion protein (PrPSc). While such diseases are rare in humans, hereditary prion diseases are triggered by genetic mutations. Some gene mutations affect the anchoring of PrPC to the cell membrane. However, it is still not fully understood exactly how these changes can trigger prion diseases.
Want more breaking news?
Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.
Subscribe for FREEIn order to gain new insights into the underlying processes, the researchers have developed new models to explore the role of a membrane anchor on the folding and aggregation of PrP in vitro and in neuronal cells. The experiments showed that anchoring to membranes stabilizes the folding of PrP and effectively inhibits aggregation. “What’s interesting is that the clumping of membrane-anchored PrP could be induced by pre-formed protein aggregates,” says Jörg Tatzelt. “This is a mechanism that might play a role in infectious prion diseases.”
Reference: Gogte K, Mamashli F, Herrera MG, et al. Topological confinement by a membrane anchor suppresses phase separation into protein aggregates: Implications for prion diseases. Proc Natl Acad Sci USA. 2025;122(1):e2415250121. doi: 10.1073/pnas.2415250121
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.
This content includes text that has been generated with the assistance of AI. Technology Networks' AI policy can be found here.
